Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF

C. S. Rosenfeld, B. Bolwell, A. LeFever, R. Taylor, A. List, J. Fay, R. Collins, F. Andrews, P. Pallansch, M. W. Schuster, D. Resta, D. Levitt, J. Nemunaitis

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Improved methods for mobilization may reduce the number of aphereses required to collect adequate numbers of peripheral blood stem cells (PBSC) and hasten engraftment following high-dose therapy. Mobilization with cytokines alone enables engraftment after myeloablative therapy. The optimal cytokine regimen for mobilization has not been established. The study evaluated the effects of four interleukin-3-containing cytokine regimens administered during steady state hematopoiesis on PBSC mobilization in 30 patients with breast cancer or lymphoid malignancies. These regimens included IL-3 alone (Arm 1), sequential IL-3 → G-CSF (Arm 2), sequential IL-3 → GM-CSF (Arm 3) and combined IL-3 + G-CSF (Arm 4). Consecutive days of apheresis were performed until a target of 4-6 x 108 mononuclear cells/kg were collected. All patients received intravenous GM-CSF after PBSC infusion. Median days to an ANC ≥ 500/μl in Arm 3 (22 days) was significantly slower than for patients in Arm 2 (13 days) but not significantly different from patients in Arm 1 or Arm 4. There was no significant difference in platelet engraftment or days of hospitalization between the study arms. Addition of GM-CSF to IL-3-containing mobilization regimens results in collection of PBSC that lead to delayed engraftment. Further development of Arms 1, 2, and 4 appear warranted.

Original languageEnglish (US)
Pages (from-to)179-183
Number of pages5
JournalBone Marrow Transplantation
Volume17
Issue number2
StatePublished - Feb 1996

Fingerprint

Interleukin-3
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Cytokines
Blood Component Removal
Hematopoietic Stem Cell Mobilization
Hematopoiesis
Peripheral Blood Stem Cells
Hospitalization
Blood Platelets
Breast Neoplasms
Therapeutics
Neoplasms

Keywords

  • Autologous bone marrow transplantation
  • Breast neoplasms
  • Granulocyte-macrophage colony-stimulating factor
  • Interleukin-3
  • Lymphoma
  • Transplantation

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Rosenfeld, C. S., Bolwell, B., LeFever, A., Taylor, R., List, A., Fay, J., ... Nemunaitis, J. (1996). Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF. Bone Marrow Transplantation, 17(2), 179-183.

Comparison of four cytokine regimens for mobilization of peripheral blood stem cells : IL-3 alone and combined with GM-CSF or G-CSF. / Rosenfeld, C. S.; Bolwell, B.; LeFever, A.; Taylor, R.; List, A.; Fay, J.; Collins, R.; Andrews, F.; Pallansch, P.; Schuster, M. W.; Resta, D.; Levitt, D.; Nemunaitis, J.

In: Bone Marrow Transplantation, Vol. 17, No. 2, 02.1996, p. 179-183.

Research output: Contribution to journalArticle

Rosenfeld, CS, Bolwell, B, LeFever, A, Taylor, R, List, A, Fay, J, Collins, R, Andrews, F, Pallansch, P, Schuster, MW, Resta, D, Levitt, D & Nemunaitis, J 1996, 'Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF', Bone Marrow Transplantation, vol. 17, no. 2, pp. 179-183.
Rosenfeld, C. S. ; Bolwell, B. ; LeFever, A. ; Taylor, R. ; List, A. ; Fay, J. ; Collins, R. ; Andrews, F. ; Pallansch, P. ; Schuster, M. W. ; Resta, D. ; Levitt, D. ; Nemunaitis, J. / Comparison of four cytokine regimens for mobilization of peripheral blood stem cells : IL-3 alone and combined with GM-CSF or G-CSF. In: Bone Marrow Transplantation. 1996 ; Vol. 17, No. 2. pp. 179-183.
@article{50035e7cfb00429b80cd8e45a1a03aeb,
title = "Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF",
abstract = "Improved methods for mobilization may reduce the number of aphereses required to collect adequate numbers of peripheral blood stem cells (PBSC) and hasten engraftment following high-dose therapy. Mobilization with cytokines alone enables engraftment after myeloablative therapy. The optimal cytokine regimen for mobilization has not been established. The study evaluated the effects of four interleukin-3-containing cytokine regimens administered during steady state hematopoiesis on PBSC mobilization in 30 patients with breast cancer or lymphoid malignancies. These regimens included IL-3 alone (Arm 1), sequential IL-3 → G-CSF (Arm 2), sequential IL-3 → GM-CSF (Arm 3) and combined IL-3 + G-CSF (Arm 4). Consecutive days of apheresis were performed until a target of 4-6 x 108 mononuclear cells/kg were collected. All patients received intravenous GM-CSF after PBSC infusion. Median days to an ANC ≥ 500/μl in Arm 3 (22 days) was significantly slower than for patients in Arm 2 (13 days) but not significantly different from patients in Arm 1 or Arm 4. There was no significant difference in platelet engraftment or days of hospitalization between the study arms. Addition of GM-CSF to IL-3-containing mobilization regimens results in collection of PBSC that lead to delayed engraftment. Further development of Arms 1, 2, and 4 appear warranted.",
keywords = "Autologous bone marrow transplantation, Breast neoplasms, Granulocyte-macrophage colony-stimulating factor, Interleukin-3, Lymphoma, Transplantation",
author = "Rosenfeld, {C. S.} and B. Bolwell and A. LeFever and R. Taylor and A. List and J. Fay and R. Collins and F. Andrews and P. Pallansch and Schuster, {M. W.} and D. Resta and D. Levitt and J. Nemunaitis",
year = "1996",
month = "2",
language = "English (US)",
volume = "17",
pages = "179--183",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Comparison of four cytokine regimens for mobilization of peripheral blood stem cells

T2 - IL-3 alone and combined with GM-CSF or G-CSF

AU - Rosenfeld, C. S.

AU - Bolwell, B.

AU - LeFever, A.

AU - Taylor, R.

AU - List, A.

AU - Fay, J.

AU - Collins, R.

AU - Andrews, F.

AU - Pallansch, P.

AU - Schuster, M. W.

AU - Resta, D.

AU - Levitt, D.

AU - Nemunaitis, J.

PY - 1996/2

Y1 - 1996/2

N2 - Improved methods for mobilization may reduce the number of aphereses required to collect adequate numbers of peripheral blood stem cells (PBSC) and hasten engraftment following high-dose therapy. Mobilization with cytokines alone enables engraftment after myeloablative therapy. The optimal cytokine regimen for mobilization has not been established. The study evaluated the effects of four interleukin-3-containing cytokine regimens administered during steady state hematopoiesis on PBSC mobilization in 30 patients with breast cancer or lymphoid malignancies. These regimens included IL-3 alone (Arm 1), sequential IL-3 → G-CSF (Arm 2), sequential IL-3 → GM-CSF (Arm 3) and combined IL-3 + G-CSF (Arm 4). Consecutive days of apheresis were performed until a target of 4-6 x 108 mononuclear cells/kg were collected. All patients received intravenous GM-CSF after PBSC infusion. Median days to an ANC ≥ 500/μl in Arm 3 (22 days) was significantly slower than for patients in Arm 2 (13 days) but not significantly different from patients in Arm 1 or Arm 4. There was no significant difference in platelet engraftment or days of hospitalization between the study arms. Addition of GM-CSF to IL-3-containing mobilization regimens results in collection of PBSC that lead to delayed engraftment. Further development of Arms 1, 2, and 4 appear warranted.

AB - Improved methods for mobilization may reduce the number of aphereses required to collect adequate numbers of peripheral blood stem cells (PBSC) and hasten engraftment following high-dose therapy. Mobilization with cytokines alone enables engraftment after myeloablative therapy. The optimal cytokine regimen for mobilization has not been established. The study evaluated the effects of four interleukin-3-containing cytokine regimens administered during steady state hematopoiesis on PBSC mobilization in 30 patients with breast cancer or lymphoid malignancies. These regimens included IL-3 alone (Arm 1), sequential IL-3 → G-CSF (Arm 2), sequential IL-3 → GM-CSF (Arm 3) and combined IL-3 + G-CSF (Arm 4). Consecutive days of apheresis were performed until a target of 4-6 x 108 mononuclear cells/kg were collected. All patients received intravenous GM-CSF after PBSC infusion. Median days to an ANC ≥ 500/μl in Arm 3 (22 days) was significantly slower than for patients in Arm 2 (13 days) but not significantly different from patients in Arm 1 or Arm 4. There was no significant difference in platelet engraftment or days of hospitalization between the study arms. Addition of GM-CSF to IL-3-containing mobilization regimens results in collection of PBSC that lead to delayed engraftment. Further development of Arms 1, 2, and 4 appear warranted.

KW - Autologous bone marrow transplantation

KW - Breast neoplasms

KW - Granulocyte-macrophage colony-stimulating factor

KW - Interleukin-3

KW - Lymphoma

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=9044219841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9044219841&partnerID=8YFLogxK

M3 - Article

C2 - 8640163

AN - SCOPUS:9044219841

VL - 17

SP - 179

EP - 183

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 2

ER -